Author: Alexander, Mariam; Kim, So Yeon; Cheng, Haiying
Title: Update 2020: Management of Non-Small Cell Lung Cancer Cord-id: vgmj9vbn Document date: 2020_11_11
ID: vgmj9vbn
Snippet: The past decade has seen a revolution of new advances in the management of non-small cell lung cancer (NSCLC) with remarkable progresses in screening, diagnosis, and treatment. The advances in systemic treatment have been driven primarily by the development of molecularly targeted therapeutics, immune checkpoint inhibitors, and anti-angiogenic agents, all of which have transformed this field with significantly improved patient outcomes. This review will address updates in lung cancer screening,
Document: The past decade has seen a revolution of new advances in the management of non-small cell lung cancer (NSCLC) with remarkable progresses in screening, diagnosis, and treatment. The advances in systemic treatment have been driven primarily by the development of molecularly targeted therapeutics, immune checkpoint inhibitors, and anti-angiogenic agents, all of which have transformed this field with significantly improved patient outcomes. This review will address updates in lung cancer screening, liquid biopsy, and immunotherapy in the front-line setting. We discuss recent advances and highlight the plethora of new approvals of molecular-targeted therapy for subgroups of NSCLC patients with sensitizing EGFR, ALK, ROS1, RET, BRAF V600E, MET, and NTRK alterations.
Search related documents:
Co phrase search for related documents- long term effect and lung cancer: 1, 2
- low toxicity and lung adenocarcinoma: 1
- low toxicity and lung cancer: 1, 2, 3, 4, 5
- low toxicity and lung cancer stage: 1, 2
- low toxicity and lung evaluation: 1, 2
- low toxicity and lymph node: 1, 2, 3
- lung adenocarcinoma and lymph node: 1, 2, 3, 4, 5, 6, 7
- lung cancer and lymph node: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57
- lung cancer and lymph node disease: 1, 2
Co phrase search for related documents, hyperlinks ordered by date